Navigation Links
Karmanos Physician-Scientists Examine Racial Disparities in,Patients with Gynecologic Cancer

of Caucasians due to a less aggressive treatment plan. These treatment plans may be prescribed by the physician, chosen by the patient, or due to a lack of treatment options.

Over seven years, Karmanos physician-scientists followed a group of 170 Caucasian and African American ovarian cancer patients through similar treatment plans, consisting of surgery and chemotherapy. The study revealed, out of the 70 percent of patients who had optimal tumor reduction surgery followed by chemotherapy, the Caucasian patients lived 16-20 months longer than the African American patients.

These results were compared to the Charlson co-morbidity index, which predicts the one-year mortality for a patient who may have a range of co-morbid conditions, such as a patient suffering from cancer along with diabetes.

"African Americans were found to have higher co-morbidity scores, meaning they may have additional factors that contribute to their cancer survivability rate," said Dr. Schimp. "Our study revealed that, in part, a patient's outcome is based on her co-morbidity score, not only on the biology of her cancer or aggressiveness of the cancer treatment."

Based in midtown Detroit, the Barbara Ann Karmanos Cancer Institute is committed to a future free of cancer. The Institute is one of 39 National Cancer Institute-designated comprehensive cancer centers in the United States. Caring for more than 6,000 new patients annually on a budget of $216 million, conducting more than 700 cancer-specific scientific investigation programs and clinical trials, the Karmanos Cancer Institute is among the nation's best cancer centers. Through the commitment of 1,000 staff, including nearly 300 faculty members, and supported by thousands of volunteer and financial donors, the Institute strives to prevent, detect and eradicate all forms of cancer. John C. Ruckdeschel, M.D. is the Institute's president and CEO.

Barbara Ann Karmanos Cancer Institute

CONTACT: Courtne
'"/>




Page: 1 2 3

Related medicine technology :

1. Early Results of the CellCept Spare the Nephron Study Examine Kidney Function
2. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
3. Late Breaking Data Released at ADA Showed that the Investigational Use of Januvia and Metformin as Initial Combination Therapy Provided Significant Glucose Lowering Efficacy over 54 Weeks in Patients with Type 2 Diabetes
4. Neurologix Announces Publication of Landmark Gene Therapy Study Demonstrating Safety and Statistically Significant Improvement in Patients With Advanced Parkinsons Disease
5. Caelyx Delays Time to Disease Progression as Maintenance Therapy in Patients with Metastatic Breast Cancer
6. Phase 2 Clinical Results of Ganite Plus Standard Therapy in Patients with Relapsed/Refractory Lymphoma Presented at ASCO
7. The Eloxatin-Based Regimen (FOLFOX4) Significantly Improved Progression Free Survival When Given Before and After Surgery in Patients With Resectable Liver Metastases From Colorectal Cancer
8. Phase 2 Clinical Results of Ganite Plus Standard Therapy in Patients with Relapsed/Refractory Lymphoma Presented at ASCO
9. First-of-Its-Kind Study Shows Botox (Botulinum Toxin Type A) Significantly Improves Idiopathic Detrusor Overactivity (IDO) in Patients With Symptoms of Overactive Bladder
10. Data Presented at the American Academy of Neurologys Annual Meeting Provide Update on Utilization and Safety of Tysabri in Patients with Multiple Sclerosis
11. Breast Cancer and HER-2/neu: Diagnostic Tools for Targeted Therapy
Post Your Comments:
(Date:2/26/2015)... 2015  Mobility Ventures LLC, an AM General Company, ... America (NYSE: BAC ) that will make ... the revolutionary MV-1 - - the world,s first and ... to provide safe and comfortable transportation for all passengers ... to purchase a new MV-1 vehicle at the over ...
(Date:2/26/2015)... -- Every year many millions of donations are obtained ... year after year doctors and the medical profession continue ... to determine the status of heart health in all ... though that technology is over 100 years old, ... (while most patients do not know) that EKG,s, in ...
(Date:2/26/2015)... JOSE, Calif. , Feb. 26, 2015  BD ... and Company) (NYSE: BDX ), a ... an innovative company focused on enabling high-resolution biology, ... their unique solutions for highly multiplexed cell isolation ... companies are promoting BD,s powerful BD FACS™ single-cell ...
Breaking Medicine Technology:Mobility Ventures and Bank of America Announce New Agreement to Simplify Retail Consumer Financing for MV-1 Universally Accessible Vehicle 2Mobility Ventures and Bank of America Announce New Agreement to Simplify Retail Consumer Financing for MV-1 Universally Accessible Vehicle 3National Heart Health Month In February 2BD and Cellular Research Announce Co-marketing Efforts for Single-Cell Sequencing 2BD and Cellular Research Announce Co-marketing Efforts for Single-Cell Sequencing 3
(Date:2/28/2015)... 2015 Mew and Company, a Vancouver ... now provide business consulting services in addition to a ... planning and succession planning. Company finances are a complicated ... On top of this, complex Canadian tax laws can ... As a result, Mew and Company works to advise ...
(Date:2/28/2015)... 2015 The Mesothelioma Applied Research ... at the International Symposium on Malignant Mesothelioma on Monday, ... the Hyatt Regency Bethesda in Bethesda, Maryland. The following ... and commitment to the mission to cure mesothelioma. , ... be presented to Miriam Ratner. Miriam runs the Meso ...
(Date:2/28/2015)... 28, 2015 A case management conference ... that have been filed by law firms including Bernstein ... in March, the Firm notes. , According to ... in the federal litigation will meet on March 13, ... prescription therapy treatments designed to raise levels of the ...
(Date:2/28/2015)... (PRWEB) February 28, 2015 The noted ... of Facial Surgery was recently featured in the January/February ... the magazine, Dr. David Ellis was featured in an ... the various cosmetic enhancements that Kim Cattrall has possibly ... , “Her forehead is smooth without horizontal lines or ...
(Date:2/28/2015)... Memphis, TN: MedixSafe has retracted a previous announcement ... reader named Guardian 2. The correct product name ... scanner that significantly increases the complexity of security ... scanner provides fast and easy access for both ... lockers with Vanguard technology tracks inventory by ...
Breaking Medicine News(10 mins):Health News:Vancouver Corporate Tax Accountants Now Provide Business Consulting Services 2Health News:Cancer Research Foundation Honors Award Recipients 2Health News:Cancer Research Foundation Honors Award Recipients 3Health News:Cancer Research Foundation Honors Award Recipients 4Health News:Bernstein Liebhard LLP Notes Approaching Conference in Federal Litigation that Includes Numerous Testosterone Lawsuits Filed by the Firm 2Health News:Bernstein Liebhard LLP Notes Approaching Conference in Federal Litigation that Includes Numerous Testosterone Lawsuits Filed by the Firm 3Health News:Bernstein Liebhard LLP Notes Approaching Conference in Federal Litigation that Includes Numerous Testosterone Lawsuits Filed by the Firm 4Health News:Dr. David Ellis Featured In Elevate Magazine 2Health News:New Name Announced For Newest MedixSafe Readers – MedixSafe Vanguard 2
... of oral steroid treatment decreases the risk of rheumatoid arthritis ... regardless of when in the course of the disease the ... observed if the steroids were taken for less than a ... treatment in rheumatoid arthritis have been a subject of much ...
... was brought to lime light when a hospital in Bangkok when ... of a 2-year old baby. The baby was suffering from ... disease and lived because of a transplant of umbilical cord blood. ... develop into a wide range of different blood cells which can ...
... Urging the medical community to develop 'much cheaper' drugs to ... said the available first and second line treatment of the ... man in the country. ,Stating that the Indian companies ... first and second line HIV drugs, Kalam said: "Even this ...
... Entertainment giant Sony has apologised to the Church of England ... game, a spokesman for the church said Friday. ... Cathedral in north-west England, saying they had not intended to ... game "Resistance: Fall of Man," he added. ...
... in 1991, an expert in the ancient art of Ikebana flower ... most of the 16 years since, Midori Yamada has taught Russians ... vases -- as attempted coups, and spectacular booms and busts played ... is very strict, each flower has its laws," she said. "With ...
... of the public health system in the US keeps tumbling ... stated that adults// with serious mental illness and treated in ... ,The gap has widened since the early '90s ... 15 years. ,"We're going in the wrong direction ...
Cached Medicine News:Health News:Long-term Oral Steroid Therapy Decreases Lymphoma Risk in Rheumatoid Arthritis 2Health News:Stem Cells- a Miraculous Boon 2Health News:Japanese Flower Art Helps Calm a Frantic Moscow 2Health News:Major Mental Disorders Cut Life Span by Ten to Fifteen Years 2
... Mo Bio Vortex Adapter in conjunction with the ... Using the Mo Bio Vortex Adapter is ... Fast Prep machines which offer the same technology. ... centrifuge tubes at one time and will fit ...
Use the Mo Bio Vortex Adapter in conjunction with the Vortex Genie 2 for rapid bead beating procedures. Using the Mo Bio Vortex Adapter is an inexpensive alternative to other bead beating and Fast Pr...
... with Vacuum Controller V-800 and water-cooled secondary condenser ... Compact Housing Model V-500 is ... handle most vacuum applications. Applications ... rotary evaporators Laboratory vacuum source for ...
... Combines BchiVac V-500 with Vacuum Controller V-800 ... vacuum levels from Model V-500 ... to handle most vacuum applications. Applications ... two rotary evaporators Laboratory vacuum source ...
Medicine Products: